Summary
The failing heart operates with an abnormal combination of heart rate, stroke volume, and enddiastolic volume. This mismatch becomes more evident during exercise of patients with heart failure, when an increase in cardiac output is achieved with higher heart rate, a lower stroke volume and a higher enddiastolic volume. Using the β 1-adrenoceptor partial agonist xamoterol which lacks β 2-adrenoceptor agonism the response of the heart to sympathetic stimulation can be modulated. At rest and low levels of exercise xamoterol provides an inotropic support of the heart, whereas it reduces inappropriate tachycardia at higher levels. Thereby, xamoterol tends to normalize the balance of the inotropic and chronotropic control of the failing heart, because cardiac output is increased with a more normal combination of heart rate, stroke volume, and filling pressure. The beneficial effects of xamoterol are discussed as being especially important for failing ischemic hearts, because the balance between energy supply and energy demand may be improved by xamoterol.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Astrand PO, Cuddy ET, Saltin B, Stenberg J (1964) Cardiac output during submaximal and maximal work. J Appl Physiol 19: 268–274
Bainbridge FA (1915) The influence of venous filling upon the rate of the heart. J Physiol 50: 6584
Barlow JJ, Main BG, Snow HM (1981) ß-Adrenoceptor stimulant properties of amidoalkylamino substituted 1-anyl-2-ethanols and 1-(aryloxy)-2-propanols. J Med Chem 24: 315–322
Barnett DB, Maguire M (1986) Comparison of the effects of chronic infusion of xamoterol and isoprenaline on rat ventricular ß-adrenoceptors. Br J Pharmacol 87: 223 P
Blackwood R, Marlow HR (1988) Xamoterol in the management of patients with exertional breathlessness and fatigue due to cardiac disease. J Am Coll Cardiol 11: 143A
Bruce RA, Hossack KF, Kusumi F, Clarke L (1979) Acute effect of oral propranolol on hemodynamic response to upright exercise. Am J Cardiol 44: 132–140
Carlsson E, Ablad B, Brandstrom A, Carlsson B (1972) Differential blockade of the chrono-tropic effects of various adrenergic stimuli in the cat heart. Life Sci 11: 953–958
Cook N, Richardson A, Barnett DB (1984) Comparison of the ß1 selective affinity of Prenalterol and Corwin demonstrated by radioligand binding. Eur J Pharmacol 98: 407–412
Detry JR, Decoster PM, Brasseur LA (1983) Haemodynamic effects of Corwin (ICI 118587) a new cardioselective ß-adrenoceptor partial agonist. Eur Heart J 4: 584–591
Detry JR, Decoster PM, Buy J, Rousseau MF, Brasseur LA (1984) Antianginal effects of Corwin: a new ß-adrenoceptor partial agonist. Am J Cardiol 53: 439–443
Epstein SE, Robinson BF, Kahler RL, Braunwald E (1965) Effects of ß-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest 44: 1745–1753
Finegan RE, Marlow AM, Harrisson DC (1972) Circulatory effect of practolol. Am J Cardiol 29: 315–322
Furnival CM, Linden RJ, Snow JM (1971 a) The inotropic and chronotropic effects of catecholamines on the dog heart. J Physiol 214: 15–28
Furnival CM, Linden RJ, Snow HM (1971 b) Reflex effects on the heart of stimulating left atrial receptors. J Physiol 218: 447–463
German and Austrian Study Group (1988) Double-blind placebo-controlled comparison of Digoxin and Xamoterol in chronic heart failure. Lancet 1: 489–493
Hetherington M, Teo KK, Haennel RG, Rossall RE, Kappagoda CT (1987) Response to upright exercise after myocardial infarction. Cardiovascular Res 21: 399–406
Higginbotham MB, Morris KG, Williams RS, McHale PA, Coleman RE, Cobb FR (1986) Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res 56: 281–291
Jennings G, Bobick A, Oddie C, Restall R (1984) Cardioselectivity, kinetics, hemodynamics and metabolic effects of xamoterol. Clin Pharmacol Ther 35: 594–602
Levy MN, Zieske A (1969) Autonomic control of cardiac pacemaker activity and atrioventricular transmission. J Appl Physiol 27: 465–470
Linden RJ, Snow HM (1974) The inotropic state of the heart. In: Linden RJ (ed) Recent advances in physiology. Churchill Livingstone, Edinburgh
Lofdahl C-G, Svedmyr N (1984) Effects of xamoterol (ICI 118587) in asthmatic patients. Br J Clin Pharmacol 18: 597–601
McCaffrey PM, Riddell JG, Shanks RG (1986) The selectivity of the partial agonist activity of xamoterol in man measured by its effects in the presence of ICI 118551. Br J Pharmacol 89: 594 P
Molajo AO, Bennett DH, Marlow HF, Snow HM, Bastain W (1987) The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease. Br J Clin Pharmacol 24: 373–379
Nuttall A, Snow HM (1982) The cardiovascular effects of ICI 118587: a ß1-adrenoceptor partial agonist. Br J Pharmacol 77: 381–388
Ohyagi A, Sasayama S, Nakamura Y, Lee JD, Kihara Y, Kawai C (1984) Effect of ICI 118587 on left ventricular function during gradual treadmill exercise in conscious dogs. Am J Cardiol 54: 1108–1113
Parker JO, West RO, Di Giorgi S (1968) Hemodynamic effect of propranolol in coronary heart disease. Am J Cardiol 21: 11–19
Pouleur H, Rousseau MF, Hanet C, Marlow HF, Charier AA (1987) Left ventricular sensitivity to ß-adrenoceptor-stimulating drugs in patients with ischaemic heart disease and varying degrees of ventricular dysfunction. Cire Res 4 [Suppl 11: 91–95
Reybrouck T, Amery A, Billiet L (1977) Hemodynamic response to graded exercise after chronic ß-adrenergic blockade. J Appl Physiol 42: 133–138
Rousseau MF, Brasseur LA, Detry JM (1973) Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease. Cardiovascular Res 7: 306–312
Sasayama S, Yokawa S, Akiyama M, Mikawa M, Sakai 0 (1986) Cardiovascular effects of ICI 118587 a new ß-adrenoceptor partial agonist in man. Jpn Circ J 50: 636–643
Sato H, Inooe M, Matsyama T, Ozaki H, Shimazu T, Takeda H, Ishida Y, Kamada T (1987) Hemodynamic effects of the ß1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction. Circulation 75: 213–220
Starling EH (1920) On the circulatory changes associated with exercise. J R Army M Corps 34: 258–272
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Snow, H.M. (1989). Modulation of the autonomic control of the failing heart. In: Just, H., Holubarsch, C., Scholz, H. (eds) Inotropic Stimulation and Myocardial Energetics. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-07908-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-07908-9_16
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-662-07910-2
Online ISBN: 978-3-662-07908-9
eBook Packages: Springer Book Archive